Skip to main content
FDA Shortage Check

Is my medication on the FDA shortage list?

Medication

Brand or generic, as on your label.

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

Latest FDA update · Klonopin (Clonazepam Tablet) · Oct 23, 2026

IN SHORTAGE

Klonopin: in shortage (FDA, Oct 24)

Check yours ↑

Tablets
A generic tablet, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Other”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated duration February 2027”. Manufacturer’s estimate, Cheplapharm Arzneimittel GmbH, Oct 16, 2026
DRUG
Klonopin
FDA LISTING
FORM
tablets
STATUS
Currently in Shortage
FIRST POSTED
Mar 10, 2023
LAST FDA UPDATE
Oct 23, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 40 presentations: 1 unavailable · 0 limited · 39 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

Every presentation of this listing

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

Report a shortage to FDA: drugshortages@fda.hhs.gov

Also from plusbeauxjours

Updated by FDA this week

55 listings updated in the 7 days up to Oct 24, 2026; the 12 newest.

Browse by form

Illustrations: AI-generated (Gemini), edited by plusbeauxjours.

How the check works

Brand or generic names, forms, strengths, what each answer means

FDA keeps a public list of drug shortages, updated from manufacturers' reports. Today it has 234 listings: 69 currently in shortage, 5 recently resolved and 160 with only discontinuation notices. The list is organized by generic name and is hard to read on a phone, so this page turns it into one answer for the medicine in your hand.

From the name on your bottle to FDA's listing

FDA writes: “We use a drug’s generic name or active ingredient as the primary listing…” So we translate the name you type into its active ingredients using FDA's NDC Directory, the federal list of drug products with their brand names, generic names, dosage forms and routes. “Klonopin” becomes clonazepam tablets; “Adderall” becomes its four amphetamine salts in tablets.

  • Ingredients must match exactly. A listing for the same ingredient with a different salt (methylphenidate patch vs. methylphenidate tablets) is shown under “Other FDA listings”, never as your answer.
  • The form matters. Every listing and every product is sorted into a dosage-form family (tablets, ER tablets, capsules, injection, inhaler, patch…) by the same rule. Lasix tablets are not furosemide injection, so you see only other forms listed, not in shortage.
  • The strength is optional. FDA's truth is per package: one maker's 2 mg can be unavailable while eleven other 2 mg packages are available. Pick your strength to see only those rows.
  • A discontinuation is product-specific. For a brand name, a notice counts only when it names that brand, so a notice about one brand isn't shown as another's.

What the answers mean

  • IN SHORTAGE: FDA lists your ingredients and form as currently in shortage. Some packages can still be available; the label shows how many.
  • RESOLVED: FDA marked the shortage resolved on the date shown. Resolved shortages remain on the list for 6 months and discontinued shortages remain on the list for 1 year.
  • DISCONTINUATION NOTICE: a maker told FDA it will stop making a product. That is not the same as a shortage.
  • OTHER FORMS LISTED: your ingredients are on the list, but in a different form than yours.
  • NOT ON FDA'S LIST: the name is a real drug in FDA's directory, and FDA lists no shortage for it. Your pharmacy can still be short.
  • NO MATCH: we couldn't find the name. It may be spelled differently or no longer marketed; try the generic name, or search FDA directly.

The stickers on the label

On a current shortage, the label carries up to three pharmacy-style stickers. Each one is FDA's own text, word for word: the shortage reason a manufacturer gave under the Food and Drug Administration Safety and Innovation Act (FDASIA), or a maker's “estimated recovery” phrase. They are labels of fact, not instructions. Illustrations: AI-generated (Gemini), edited by plusbeauxjours.

Privacy

The check runs in your browser. Your medication never goes into the page address, analytics or storage. To suggest names, the page downloads a public list of names for the first letter you type, so at most that letter leaves your device. Analytics records only the kind of answer (for example “in shortage”), never the drug.

What each FDA status means

FDA's definitions, word for word
  • Currently in Shortage: “A situation in which the total supply of all clinically interchangeable versions of an FDA-regulated drug is inadequate to meet the current or projected demand at the user level.”
  • Resolved: “A situation in which the market demand is covered and no supply issues are anticipated by the manufacturers.”
  • Discontinuation: “A situation in which a specific drug product is no longer being commercially distributed by an FDA-regulated manufacturer… Note that a discontinuation in the manufacture of a specific drug product does not necessarily create a shortage, because there may be other manufacturers supplying the same or clinically interchangeable products.”

Source: FDA Drug Shortages database FAQ ↗

Why we never name an alternative

FDA calls it the practice of medicine

“Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” (FDA)

We follow FDA: no “switch to”, no substitutes, no dose conversions. Listings that share an ingredient with yours are shown only with their FDA status. Your pharmacist or prescriber can talk through options with you. ASHP also tracks shortages and suggested alternatives, using different criteria.

What FDA's list covers, and what it doesn't

Scope, retention, manufacturer-reported data
  • “Shortages that are expected to be resolved quickly, shortages that involve only a particular strength or package size, and shortages where a substitute strength(s) or package size(s) is available are not usually the focuses of FDA’s program.” (FDA)
  • Resolved shortages remain on the list for 6 months and discontinued shortages remain on the list for 1 year. (FDA)
  • Availability, recovery estimates and reasons come from manufacturers. FDA publishes them; we copy them without changing a word.
  • A name we can't find may be a brand that is no longer marketed. Try the generic name, or look it up in Drugs@FDA ↗.
  • Local shortages, a single pharmacy's stock and wholesaler backorders are not on FDA's list. FDA's consumer FAQ suggests checking other pharmacies (FDA ↗).

openFDA's disclaimer, which applies to the openFDA data we use for routes and names:

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.

Sources

FDA checked Oct 24, 2026 · read October 25, 2026

Every availability, reason, note and date on this page is FDA's or the manufacturer's own text. The badge, the one-line answer and the grouping are ours. Data from FDA Drug Shortages and openFDA. plusbeauxjours is not a government site.

Questions

Adderall, end dates, alternatives, local shortages

How do I check if my medication is on the FDA shortage list?

Type the name on your bottle, brand or generic, and pick it from the list. If the name comes in more than one form, tap yours (tablets, ER capsules, injection…), and pick your strength if you like. FDA lists shortages by generic name, so a brand is matched through its active ingredients and form.

Is Adderall still in shortage?

Yes, as of Oct 24, 2026. FDA lists the immediate-release Adderall tablet ingredients (Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet) as currently in shortage: of 73 presentations, 19 are unavailable, 9 limited and 45 available. FDA last updated the listing Oct 23, 2026. Adderall XR is a different form (extended-release capsules); type it above to check it separately.

Adderall on FDA's list, by strength and maker

What do “Currently in shortage”, “Resolved” and “Discontinuation” mean?

FDA's definitions. Currently in shortage: “A situation in which the total supply of all clinically interchangeable versions of an FDA-regulated drug is inadequate to meet the current or projected demand at the user level.” Resolved: “A situation in which the market demand is covered and no supply issues are anticipated by the manufacturers.” Discontinuation: “A situation in which a specific drug product is no longer being commercially distributed by an FDA-regulated manufacturer… Note that a discontinuation in the manufacture of a specific drug product does not necessarily create a shortage, because there may be other manufacturers supplying the same or clinically interchangeable products.”

When will the shortage end?

FDA gives no single end date. Each manufacturer reports its own estimate per product, and those estimates change and often disagree (“TBD”, “October 2026”, “April 2027” for the same drug). We quote them word for word with the date each maker gave it, and we never calculate an end date ourselves.

Does FDA list alternatives?

No. FDA: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Ask your pharmacist or prescriber. ASHP also tracks shortages and suggested alternatives, using different criteria.

My pharmacy is out, but FDA doesn't list it. Why?

FDA's list covers medically necessary products nationally. FDA: “Shortages that are expected to be resolved quickly, shortages that involve only a particular strength or package size, and shortages where a substitute strength(s) or package size(s) is available are not usually the focuses of FDA’s program.” And from FDA's consumer FAQ: “If you can’t find your medication at your local pharmacy or store, it may be due to a temporary, localized supply issue. Check multiple stores or pharmacies, or ask your health care provider or pharmacist if there is an alternative to the medicine you’re looking for.”

How often is this updated?

FDA: “We update the drug shortages searchable database daily.” “The majority of information is provided to FDA by manufacturers.” We check FDA's list twice a day, and every answer shows the date we checked.

How do I report a shortage?

Email FDA at drugshortages@fda.hhs.gov about a shortage already on the list, or use FDA's CDER NextGen portal to report a new one.

Details